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 INTRODUCTION 
 Japanese encephalitis virus (JEV), a mosquito-borne virus, is 
the most common cause of vaccine-preventable viral encepha-
litis in Asia. 1, 2 Japanese encephalitis virus is transmitted in an 
enzootic cycle between animal hosts, mostly pigs and wading 
birds, and mosquito vectors; humans are incidental, dead-end 
hosts. 3 Japanese encephalitis (JE) is endemic in most parts 
of Asia and the Western Pacific where approximately three 
billion people live. 4, 5 An estimated 30,000 to 50,000 human JE 
cases occur annually; the case fatality is 10–30% and 30–50% 
of survivors develop long-term neurologic and psychiatric 
sequelae. 2, 6 
 Bangladesh shares a similar ecology with its JE-endemic 
neighboring countries of India and Nepal, where several 
large outbreaks of JE have been identified in recent years. 5, 7 
One confirmed JE outbreak was reported from Bangladesh 
in 1977, but there are no data on the incidence of JE cases 
because of limited diagnostic capacity and a lack of systematic 
disease surveillance. 8 A hospital-based study conducted from 
2003 to 2005 to assess the etiologies of encephalitis at four 
hospitals in Bangladesh found that among 492 patients with 
clinical encephalitis, 20 (4%) cases had laboratory evidence of 
recent JEV infection. 9 
 The incidence of JE has been reduced dramatically in Japan, 
Korea, Taiwan, China, and Thailand since the introduction of a 
JE vaccine into the national immunization programs of these 
countries. 10– 14 Widely used live attenuated SA 14-14-12 JE vac-
cine is inexpensive and with a single dose provides 80–96% 
protection. 6, 15, 16 The introduction of a life saving vaccine in 
a low income country such as Bangladesh depends on the 
cost-effectiveness, which in turn depends on the incidence of 
disease. 
 Since 2007, the Institute of Epidemiology, Disease Control 
and Research (IEDCR) of the Government of Bangladesh, in 
collaboration with other partners, has been conducting acute 
meningoencephalitis syndrome surveillance in three tertiary 
level hospitals where patients admitted with symptoms of 
meningoencephalitis were tested for JE. However, hospital-
based surveillance data underestimates the true burden of 
disease because many ill persons do not seek treatment at sur-
veillance hospitals. 17– 19 To adjust crude the estimates of hospital-
based incidence, instead of using a traditional house-to-house 
survey, which is expensive for a disease with low frequency, 
we used a novel method to identify meningoencephalitis cases 
from the hospital catchment area. We leveraged the close 
social networks within Bangladeshi rural communities who 
actively discuss community events, such as family illness, and 
are generally able to report any serious health events experi-
enced by their neighbors, to identify study participants in our 
community-based survey. 
 Because the population-based incidence of JE is of particu-
lar interest in Bangladesh, and vaccines are available and now 
being used in many countries, we estimated JE incidence in 
the three hospitals’ catchment areas by adjusting the crude 
hospital-based JE incidence by the proportion of catchment 
area meningoencephalitis cases who were admitted to surveil-
lance hospitals. 
 MATERIALS AND METHODS 
 Hospital-based surveillance.  In October 2007, acute menin-
goencephalitis surveillance was initiated at Rajshahi Medical 
College Hospital, Khulna Medical College Hospital, and 
Chittagong Medical College Hospital, which are tertiary 
care referral hospitals in three different parts of the country 
( Figure 1 ). For the purposes of this surveillance, we defined a 
case of meningoencephalitis as a patient who had acute onset 
of fever with altered mental status, or new onset of seizures, 
or signs of meningeal irritation. Surveillance physicians 
collected clinical information from all patients identified 
with meningoencephalitis and coordinated the collection 
of cerebrospinal fluid (CSF) and two samples of serum; one 
at admission and another at discharge. The specimens were 
divided into aliquots at the study sites, stored at −20°C, and 
transported weekly to the Institute of Public Health, Dhaka for 
laboratory testing of JE and then preserved at −70°C. The CSF 
samples were tested for anti-JEV immunoglobulin M (IgM) 
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antibodies using the XCyton enzyme-linked immunosorbent 
assay (ELISA) kit. 20 Serum samples were tested for JEV and 
dengue virus IgM antibodies using the Panbio ELISA kit. 21 A 
case of JE was defined as a patient with meningoencephalitis 
and anti-JEV IgM antibodies identified in a CSF or serum 
sample. Laboratory quality control was routinely assessed 
by proficiency panel samples testing and an onsite visit of 
a virologist from the World Health Organization (WHO), 
South-East Asia Regional Office, India. A subset of aliquots 
were also sent to the reference laboratory in Centers for 
Disease Control and Prevention (CDC) in Fort Collins, CO 
for quality assurance and further testing for potential causes 
of meningoencephalitis. 
 Hospital catchment area assessment.  Catchment area and 
survey cluster selection.  We conducted a survey in the catchment 
area of surveillance hospitals to calculate the proportion of 
persons with symptoms of meningoencephalitis in the hospital 
catchment area who were admitted to the surveillance hospital. 
We defined the primary catchment area of a surveillance 
hospital as the districts where more than 50% of the admitted 
meningoencephalitis patients resided. Applying this criterion 
to the hospital records from November 2007 to April 2008, 
we selected Rajshahi, Naogaon, Chapai-Nawabgonj districts 
as the catchment area of Rajshahi Medical College Hospital; 
Khulna, Jessore, Jhenaidah, Narail, Satkhira, and Bagerhat 
districts as the catchment area of Khulna Medical College 
Hospital; and Chittagong and Cox’s Bazar districts as the 
catchment area of Chittagong Medical College Hospital 
( Figure 1 ). For the community-based survey, we selected 20 
unions, the lowest administrative area in Bangladesh, from 
each of these three hospital catchment areas using a probability 
proportional to size sampling approach. We first listed all the 
unions in a hospital catchment area by their population in a 
spreadsheet and calculated the sampling interval by dividing 
the total population by 20, and then selected a random number 
between one and the sampling interval. The union having the 
cumulative population that captured the random number was 
selected as the first union. To select the second union, the 
sampling interval was added to the random number and again 
the list was consulted to see which union included that number. 
This process was repeated until all 20 unions were indentified. 
The average population of each selected union was 27,000 and 
three were in urban metropolitan areas. 
 Study population.  In the community, we classified persons as 
having symptoms compatible with meningoencephalitis if they 
developed fever with altered mental status, or unconsciousness, 
or a new onset seizure within the last 12 months. To rule out 
epilepsy as the cause of disease, we excluded persons who 
had experienced multiple seizures within a 6-month interval 
during the previous 2 years. 
 Data collection technique.  In the selected rural unions of 
the hospital catchment area, the field team first approached 
key informants, including local health care providers, religious 
and community leaders, educational institutions and vendors, 
and customers in the village market. The team then walked 
through the village and met with some of the residents, 
especially women, in several informal courtyard gatherings, 
usually consisting of 6–7 households. The team explained the 
symptoms of meningoencephalitis in local terms and asked 
the people if they knew anybody in their community who had 
developed fever with unconsciousness or altered mental status 
or a new onset seizure in the previous one year. If the team 
received information about anyone with meningoencephalitis 
symptoms, they visited that household to confirm that the 
person’s symptoms met our classification of symptoms com-
patible with meningoencephalitis. If the person’s symp toms 
were compatible with meningoencephalitis, the study team 
administered a structured questionnaire to the affected person 
and/or his/her care givers during the illness that included 
questions on whether the person sought care at a surveillance 
hospital. The study team also documented the illness history 
and outcomes, along with demographic characteristics and 
healthcare seeking behavior. 
 In the selected urban clusters, the team began with the same 
community networking approach to identify meningoenceph-
alitis cases. However, this approach failed in the urban com-
munities because people in these areas did not know their 
neighbors well and was less aware of serious family events 
experienced by their neighbors. Therefore, house-to-house 
surveys were used instead of community networking in urban 
areas. Two field teams, each with three research assistants 
and one supervisor, worked from June 2008 to March 2009 to 
complete the survey in the three hospital catchment areas. 
 JE incidence calculation.  To focus on those persons hav-
ing symptoms compatible with meningoencephalitis from the 
catchment area that most likely represented actual enceph-
alitis, in our final incidence calculation we defined suspected 
meningoencephalitis as people who developed fever with at 
least 6 hours of altered mental status, or at least 1 hour of 
unconsciousness, or new onset seizure (jerking in body) within 
the last 12 months. 
 Because many meningoencephalitis cases in hospital catch-
ment areas do not seek care at the surveillance hospitals, our 
 Figure 1.  Map of Bangladesh showing surveillance hospitals and 
catchment areas. 
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premise was that if all of them did go to the surveillance hos-
pitals we could then estimate the real population-based JE 
incidence. We first calculated the hospital-based JE incidence 
by dividing the number of confirmed JE cases admitted to 
study hospitals within the last 1 year from the catchment area 
by the total catchment population. We then estimated popu-
lation-based JE incidence by adjusting this hospital rate by 
the proportion of suspected meningoencephalitis cases in the 
catchment area who were admitted to these surveillance hos-
pital using the following formula:
 
Incidence of JE =
 
J
*100,000,
D
N *  *
12
P
where 
 J =  Number of JE cases identified in the surveillance hospital 
from within the catchment area; 
 N = Population of the hospital catchment area; 
 D = Duration of surveillance in months; and 
 P =  Proportion of suspected meningoencephalitis cases in 
the catchment area who were admitted to surveillance 
hospital. 
 Data analysis.  The population of each catchment area was 
projected for 2008 on the basis of the 2001 Bangladesh census 
considering the annual growth rate of 1.4%. 22 The annual 
growth rate was estimated using crude birth rate, net external 
migration, and national crude death rate. 23 We used a linear 
mixed effect model to adjust the cluster effects in calculating the 
proportion of meningoencephalitis cases who were admitted to 
surveillance hospitals and estimated the incidence of JE with 
95% confidence intervals (CI) for each hospital catchment 
area. Most patients with JE have IgM antibodies detectable 
in convalescent CSF and serum specimens collected ≥ 7 days 
of onset of illness. 24– 26 Because we were unable to collect 
the convalescent specimens from all enrolled patients in the 
surveillance hospitals, we estimated the potential impact of the 
limited availability of convalescent specimens on the incidence 
of JE by applying the JE positivity rate of convalescent phase 
specimens to the acute phase specimens collected from 
the admitted patients. We performed a two-sample test of 
proportion to compare the demographic characteristics and 
clinical signs between cases admitted and not admitted to 
surveillance hospitals. We also performed the Wilcoxon rank-
sum test to compare the distance between the surveillance 
hospital and villages of both admitted and not admitted cases. 
 Ethical concerns.  The field team obtained written informed 
consent from the identified meningoencephalitis cases or their 
guardians. Assent was taken from participants between 7 and 
17 years of age. Because the hospital surveillance was a national 
surveillance activity under the Ministry of Health and Family 
Welfare, written informed consent was not required from 
the admitted meningoencephalitis cases. The study protocol 
was reviewed and approved by institutional review boards 
of the International Center for Diarrheal Disease Research, 
Bangladesh (ICDDR,B) and the CDC. 
 RESULTS 
 Hospital-based surveillance.  In the hospital-based surveil-
lance, 886 patients were enrolled from October 2007 through 
December 2008 and of these patients, 875 (99%) provided at 
least one serum or CSF specimen for JE testing. Among the 
886 enrollees, 55 (6%) had laboratory evidence of recent JEV 
infection ( Table 1 ). Overall, 705 (80%) of the 886 patients with 
meningoencephalitis and 38 (69%) of the 55 JE cases were 
admitted from the catchment districts of surveillance hospitals. 
Among the 38 JE cases from the catchment area, 68% were 
male and 45% were ≤ 15 years of age. They presented with 
fever (100%), altered mental status (95%), unconsciousness 
(38%), and new onset seizure (83%). 
 Assessment of hospital catchment area.  From the community-
based hospital catchment survey, the field team identified 1,161 
people with symptoms compatible with meningoencephalitis 
within the preceding 12 months. Of these, 969 (83%) met the 
suspected meningoencephalitis case definition. 
 In the catchment area, 74% of suspected meningoencepha-
litis cases selected unqualified health care providers who had 
no institutional medical training qualifications, as their first 
choice in seeking health care. However, over their entire ill-
ness duration, 78 (8%) suspected meningoencephalitis cases 
were admitted to a surveillance hospital and 533 (55%) 
cases sought care from other qualified health care providers 
( Table 2 ). Distance was an important factor in seeking treat-
ment at surveillance hospitals; the median distance between 
the surveillance hospital and the village of suspected menin-
goencephalitis case was 28 km for cases who were admitted to 
a surveillance hospital, but was 45 km for cases not admitted 
( P < 0.01). 
 Of the 969 suspected meningoencephalitis cases in the 
community-based survey, 60% were male. Children < 5 years 
of age accounted for 35% of suspected meningoencephalitis 
cases that were admitted to surveillance hospitals, but made 
up 69% of suspected cases who were not admitted to surveil-
lance hospitals ( P < 0.001). Of the reported clinical signs of 
the suspected meningoencephalitis cases, new onset of seizure 
was higher among suspected cases who were not admitted, 
whereas neck stiffness was higher among suspected cases who 
were admitted to surveillance hospitals. Although the propor-
tion of altered mental status and unconsciousness was similar 
in both admitted and not admitted cases, the duration of ill-
ness was significantly higher among admitted cases ( Table 3 ). 
 Incidence estimation.  Among the 38 laboratory-confirmed 
JE cases admitted from the catchment areas of the three 
surveillance hospitals, 24 cases were from Rajshahi, 8 from 
Khulna, and 6 from Chittagong. Among the suspected 
 Table 1 
 Laboratory-confirmed Japanese encephalitis cases by surveillance 
hospitals, October 2007–December 2008 * 
Description
Surveillance Medical College Hospital
TotalRajshahi Khulna Chittagong
Patients admitted with 
meningoencephalitis
550 147 189 886
At least one sample 
tested
547 (99%) 139 (95%) 189 (100%) 875 (99%)
Admission CSF 
samples tested
342 (61%) 106 (72%) 176 (94%) 624 (70%)
Admission serum 
samples tested
425 (77%) 138 (94%) 179 (95%) 742 (84%)
Discharge serum 
samples tested
57 (10%) 51 (35%) 4 (2%) 112 (13%)
JE positive cases 33 (6.0%) 10 (6.8%) 12 (6.3%) 55 (6.2%)
 *  CSF = cerebrospinal fluid. 
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meningoencephalitis cases in the hospital catchment area, a 
small proportion of cases visited the surveillance hospitals 
during their illness; 11% in Rajshahi, 4% in Khulna, and 9% 
in Chittagong ( Table 4 ). Using the formula to measure the 
population-based incidence of JE through catchment area 
population, the catchment adjusted incidence of JE ranged 
from 0.6/100,000 population in Chittagong to 2.7 in Rajshahi 
( Table 4 ). The estimated incidence of JE was higher among 
children in all of the hospital catchment areas. Among the 
population < 15 years of age, the adjusted incidence was 4.7 
in Rajshahi, 3.0 in Khulna, and 1.2 in Chittagong/100,000 
population ( Table 4 ). 
 Potential impact of limited availability of convalescent 
specimen.  Among the 705 enrolled patients admitted to 
the surveillance hospitals from the catchment areas (392 in 
Rajshahi, 144 in Khulna, and 169 in Chittagong), 319 (45%) 
had a serum or CSF sample that was collected ≥ 7 days after 
their onset of illness; of these, 26 (8.2%) were positive for anti-
JEV IgM antibodies. In comparison, only 12 (3.1%) of the 
remaining 386 patients who had a sample collected < 7 days 
after onset of illness had evidence of anti-JEV IgM antibodies 
( P < 0.005). Applying the JE positivity rate for patients who 
had a specimen from ≥ 7 days after onset of illness available 
for testing to the meningoencephalitis patients who had only 
an acute specimen collected, we estimate that 20 additional JE 
cases would have been identified (12 in Rajshahi, 3 in Khulna, 
and 5 in Chittagong). Using these assumptions, the adjusted 
 Table 2 
 Health care seeking behavior of suspect meningoencephalitis cases in 
the hospital catchment area ( N = 969) 
Health care seeking First visit n (%) Second visit n (%) Any visit n (%)
Unqualified practitioners * 717 (74) 186 (19) 922 (95)
Surveillance hospitals 9 (1) 26 (3) 78 (8)
Other qualified practitioners  233 (24)  226 (23)  538 (55) 
Health and Family 
Welfare Center
18 (2) 3 (0) 22 (2)
Upazila Health Complex 42 (4) 59 (6) 120 (12)
Private practitioner 91 (10) 86 (9) 198 (20)
District hospital 11 (1) 21 (2) 45 (5)
Private clinic 33 (3) 30 (3) 82 (9)
Pediatric hospital 38 (4) 27 (3) 71 (7)
 *  Having no medical training qualifications. 
 Table 3 
 Demographic characteristics and reported clinical signs of suspect 
meningoencephalitis * cases in the hospital catchment area 
Characteristics
Admitted at study 
hospital ( N = 78) n (%)
Not admitted at study 
hospital ( N = 891) n (%)  P value † 
 Male 46 (59) 531 (60) 0.86
Age group
 < 5 years 27 (35) 612 (69) < 0.001
 6–14 years 18 (23) 146 (16) 0.11
 > 14 years 33 (42) 133 (15) < 0.001
Reported clinical signs
 New onset seizure 63 (81) 828 (93) < 0.001
 Stiff neck 20 (26) 70 (8) < 0.001
 Altered mental status 74 (95) 819 (92) 0.34
  > 6 hours 59 (76) 121 (14) < 0.001
 Unconsciousness 60 (77) 750 (84) 0.11
  > 1 hour 54 (69) 308 (35) < 0.001
 *  Suspect meningoencephalitis cases was defined as people who developed fever with at 
least 6 hours of altered mental status, or at least 1 hour of unconsciousness, or new onset sei-
zure (jerking in body) within the last 12 months. 
 † Two-sample proportion test was applied to compare the characteristics between admitted 
and not admitted cases. 
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incidence of JE would be 4.0 (95% CI = 2.8–7.5) per 100,000 
population in Rajshahi, 2.0 (95% CI = 1.2–5.6) in Khulna, and 
1.0 (95% CI = 0.8–1.6) in Chittagong. 
 DISCUSSION 
 This is the first study in Bangladesh to estimate the pop-
ulation-based incidence of JE. The estimated incidence var-
ied in different parts of the country, with the highest in the 
Rajshahi area, in northwestern Bangladesh (2.7/100,000 popu-
lation). This rate is similar to the JE incidence of some other 
JE endemic countries before the introduction of a JE vaccine 
into the national immunization programs; in Taiwan the inci-
dence was 2.1 and in Thailand the incidence was 3–5/100,000 
population. 27, 28 Nepal has recently focused on a mass immu-
nization program of JE in their 20 endemic and four hyper-
endemic districts where the incidence of JE was 1.6/100,000 
population in JE-endemic districts. 29– 31 
 Identifying the highest JE incidence in the Rajshahi Medical 
College Hospital catchment area is consistent with the hos-
pital-based JE study conducted in 2003–2005, where over 
half of the cases (11 of 20) were identified from this hospital 
among four study hospitals. 9 A higher number of JE cases in 
Rajshahi may result from the local ecology. The mosquito vec-
tor of JE breeds prolifically in wet fields, especially in paddy 
fields. 32 The Rajshahi area is famous for rice and other agricul-
tural products and the proportion of people directly involved 
in agriculture is higher than any other area of the country. 33 
Although pig raising is not common in Bangladesh’s predom-
inately Muslim communities, indigenous and tribal people 
commonly raise pigs, including the  Santal, the most populous 
indigenous community living in northwestern Bangladesh. 34 
The actual pig density is not known, but a recent pig census 
conducted in three catchment districts of Rajshahi Medical 
College Hospital indentified over 11,000 pigs, which were 
well distributed throughout the districts (Khan SU, personal 
communication) . 
 The vast majority of JEV infections are asymptomatic 
and the clinical features of JE have a broad spectrum, rang-
ing from a mild flu-type illness to a severe meningoenceph-
alitis. 6 The case definition of suspect meningoencephalitis in 
the catchment survey included similar clinical signs to those 
used for the case definition in surveillance hospitals to enroll 
the patients for JE testing. However, the presenting clinical 
signs, in terms of duration of altered mental status and uncon-
sciousness, were more severe among admitted cases in surveil-
lance hospitals than those of cases who were not admitted. The 
severity of illness of these admitted patients could be higher 
because surveillance at the tertiary level hospital captures 
patients with more severe illnesses. 35, 36 In Bangladesh, people 
initially seek care from local health care providers, either qual-
ified or unqualified. Of the identified suspected meningoen-
cephalitis cases, only 1% of cases visited a surveillance medical 
college hospital as their first visit to any health care provider 
even though many of these people lived quite close to that sur-
veillance hospital. 
 Although only 45% of hospital-confirmed JE cases were 
< 15 years of age, in the catchment area of all study hospitals 
the estimated incidence of JE was higher among children com-
pared with adults, which is similar to other studies conducted 
in JE-endemic countries. 30, 37, 38 In the catchment area more 
than two-thirds of the suspected meningoencephalitis cases 
were found in children < 5 years of age, but these cases were 
less likely to be admitted to the surveillance hospitals. For ter-
tiary level health care, people preferred pediatric hospitals for 
the treatment of their children instead of medical college hos-
pitals ( Table 2 ). However, as no pediatric hospital is available 
in the Rajshahi area, all children admitted to pediatric hospi-
tals were identified from the Chittagong and Khulna area. 
 The approach used in this study, to estimate the population-
based incidence of JE by adjusting crude incidence based on 
healthcare facility usage, builds on approaches used by other 
investigators in other settings to estimate the incidence of 
other diseases of public health importance. 35, 39, 40 Incidence esti-
mation of a disease with low frequency requires a large sam-
ple. The average population of our survey area (20 unions) in 
each hospital catchment area was more than 500,000. Rather 
than traditional door-to-door visits, which would be relatively 
expensive, we deployed a novel low-cost practical approach 
leveraging the strong social networks of rural Bangladeshi 
communities to identify persons with symptoms compatible 
with meningoencephalitis in the rural study areas. A typical 
village in Bangladesh is made up of a number of neighbor-
hoods ( paras ) that are composed of a group of homesteads 
( baris ). 41 A  bari usually consists of 6–7 households around a 
single courtyard and generally it’s members are patrilineally 
related; in a  para people are generally involved in the same 
occupation and are closely related to each other. 41, 42 Hence, 
because of deep kinship prevailing in rural Bangladesh, resi-
dents are quite knowledgeable of major events that occurred 
in the other’s households. As the field team visited the village 
doctors, educational institutions, and various groups in the vil-
lage market, in addition to courtyard gathering, they usually 
received information of a suspected meningoencephalitis case 
from multiple sources. Although this community networking 
approach did not work in the three urban clusters because 
of weaker social networks among the urban dwellers, the 
approach may be efficient in identifying persons with severe 
diseases in other areas where strong social networking exist. 
 We note certain study limitations. First, the adjusted inci-
dence assumes that meningoencephalitis patients who were 
admitted to the study hospital had a similar likelihood of hav-
ing JEV infection as patients who received care elsewhere. 
However, the cases who were admitted to the study hospital 
were older, sicker, and lived closer to the hospital than the 
other meningoencephalitis cases. However, whether these dif-
ferences would result in an increased or decreased proportion 
of the hospitalized cases being caused by JE is unknown and, 
therefore, could not be accounted for in the analysis. Second, 
in the surveillance hospitals only 45% of admitted patients 
had a CSF or serum specimen collected ≥ 7 days of onset of ill-
ness. This limited availability of convalescent specimens would 
underestimate the incidence of JE, so we made an additional 
estimate of incidence that accounted for this underestima-
tion. Our estimate would be more precise if we were actually 
able to test the convalescent sera of all patients. Third, we col-
lected information on persons who had symptoms compatible 
with meningoencephalitis using a community-based survey, 
usually collected months after the acute illness. However, as 
our trained field team explained the symptoms of meningo-
encephalitis to the villagers in local terms, we believe that the 
reports of seizures and altered consciousness, especially coma, 
were reliably reported by lay persons and therefore provide a 
reasonable estimate of the proportion of persons with serious 
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central nervous system infections living in hospital catchment 
areas. 
 The data obtained from this study provides a credible esti-
mate of the JE incidence in three wide geographic areas in 
Bangladesh that can be used as a rationale for policymakers 
to take effective control measures. Vaccination is the most 
effective means to control the incidence of JE. 43 Current JE 
vaccines are safe and inexpensive 3 ; the neighboring coun-
tries of Bangladesh, such as India, Nepal, and Sri Lanka, have 
recently introduced JE vaccine into their JE endemic regions. 
Bangladesh should consider a vaccine demonstration project 
in areas where the incidence is high, especially in Rajshahi, 
and should assess the cost-effectiveness of vaccine introduc-
tion in the routine childhood immunization program. 
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